Related Experiment Video
Updated: Jul 2, 2025
05:12
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
904
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina N Ali1, Hossam M Ali1, Matthew R Lopez1
1Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN 55905, USA.
Cells
|February 23, 2024
Summary
Astrocytes regulate gamma-aminobutyric acid (GABA), a key neurotransmitter. Dysregulation of astrocytic GABA is linked to alcohol use disorder (AUD) and major depressive disorder (MDD).
Area of Science:
- Neuroscience
- Cell Biology
- Psychiatry
Background:
- Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS).
- Astrocytes, the brain's main glial cells, synthesize and release GABA, influencing neuronal activity and homeostasis.
- Astrocytic GABA regulation is increasingly recognized for its role in neurological and psychiatric conditions.
Purpose of the Study:
- To review the role of astrocytic GABA regulation in alcohol use disorder (AUD) and major depressive disorder (MDD).
- To summarize current understanding and ongoing debates regarding the mechanisms of astrocytic GABA regulation.
- To highlight potential therapeutic targets for AUD and MDD related to astrocytic GABA.
Main Methods:
- Literature review of studies on astrocytic GABA synthesis, release, and receptor activation.
- Analysis of evidence linking astrocytic GABA dysregulation to AUD and MDD.
- Synthesis of current research on therapeutic strategies targeting astrocytic GABA.
Main Results:
- Astrocytic GABA plays a critical role in maintaining CNS homeostasis and synaptic function.
- Evidence strongly implicates astrocytic GABA dysregulation in the pathophysiology of AUD and MDD.
- Pharmacological agents targeting GABA are under investigation for AUD and MDD treatment.
Conclusions:
- Astrocytic GABA regulation is a significant factor in the molecular basis of AUD and MDD.
- Understanding these mechanisms offers promising avenues for novel therapeutic interventions.
- Further research is needed to fully elucidate astrocytic GABA's role and optimize treatment strategies.
Keywords:
GABAGABA receptorGABA transporteralcohol use disorderamygdalaastrocyteglobus pallidusmajor depressive disorderMore Related Videos
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
209
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
209
01:28Depressants
116
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
116
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:14CNS Depressants: Barbiturates and Benzodiazepines
265
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
265